Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRINOX-Losartan and Proton Radiation with Capecitabine for Locally Advanced Pancreatic Cancer
NCT01821729Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2013
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in pancreatic cancer (PC), sponsored by Massachusetts General Hospital. Started Aug 2013; status: completed.
02
Drugs
losartan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01821729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821729.